Key Developments: Synergetics USA Inc (SURG.W)
3.18USD
21 May 2013
$0.05 (+1.60%)
$3.13
$3.13
$3.18
$3.13
200
331
$5.45
$2.94
Latest Key Developments (Source: Significant Developments)
Synergetics USA Inc Comments On FY 2013 Guidance
Synergetics USA Inc announced that it anticipates improving financial performance in fiscal 2013, both in terms of revenue and EPS growth, despite of planned investments to drive new product introductions and the incremental expenses related to the medical device tax this year. Full Article
Synergetics USA Inc Announces FDA Clearance Of VersaVIT Vitrectomy System
Synergetics USA Inc announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for VersaVIT(TM), a vitrectomy system for the retinal surgery market. Full Article
Synergetics USA Inc Issues Q3 2012 Guidance Below Analysts' Estimates
Synergetics USA Inc announced that for the third quarter of 2012, it expects net sales to be approximate $14.4 million to $14.7 million and net income per share (EPS) of approximately $0.04 to $0.06. According to I/B/E/S Estimates, analysts were expecting the Company to report revenues of $16.25 million and EPS of $0.09 for the third quarter of 2012. Full Article
Synergetics USA Inc Issues Q1 2012 Guidance Below Analysts' Estimates
Synergetics USA Inc announced that for the first quarter of 2012, it expects to report revenue of $13.3-$13.6 million and earnings from continuing operations of $0.04 to $0.05 per share (EPS). According to I/B/E/S Estimates, analysts were expecting the Company to report revenues of $14.2 million and EPS of $0.06 for the first quarter of 2012. Full Article
Synergetics USA Inc Issues Q4 2011 Guidance
Synergetics USA Inc announced that for the fourth quarter of 2011, it expect to report sales of approximately $15.8 million and net income of approximately $2.0 million. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $15.86 million and net income of $2.1 million for the fourth quarter of 2011. Full Article

Earnings vs.
Estimates